Iron deposition in Parkinson’s disease by quantitative susceptibility mapping

BACKGROUND: Patients with Parkinson’s disease (PD) have elevated levels of brain iron, especially in the nigrostriatal dopaminergic system. The purpose of this study was to evaluate the iron deposition in the substantia nigra (SN) and other deep gray matter nuclei of PD patients using quantitative s...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qiqi, Chen, Yiting, Zhang, Yue, Wang, Furu, Yu, Hongchang, Zhang, Caiyuan, Jiang, Zhen, Luo, Weifeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532252/
https://www.ncbi.nlm.nih.gov/pubmed/31117957
http://dx.doi.org/10.1186/s12868-019-0505-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6532252/
https://www.ncbi.nlm.nih.gov/pubmed/31117957
http://dx.doi.org/10.1186/s12868-019-0505-9

Ejemplares similares